-
News | 2022.03.22
Ukrainian scientists: offer to join a host laboratory at the Institut Pasteur in Paris
In view of the ongoing war in Ukraine, the Institut Pasteur is providing funding to host Ukrainian scientists in its research laboratories.
-
Article | 2016.12.20
Amgen Scholars Program
The Amgen Scholars Program at Institut Pasteur will provide ten undergraduate students from European universities the opportunity to work on supervised research projects during an eight-week summer internship in Institut Pasteur.
-
Document de presse | 2020.04.30
Revealing how SARS-CoV-2 hijacks human cells; points to drugs with potential to fight COVID-19 and a drug that aids its infectious growth
An international effort including researchers from University of California San Francisco (UCSF), Gladstone Institutes, Icahn School of Medicine at Mount Sinai and Institut Pasteur (Paris) unveils promising compounds for clinical testing against COVID-19. The study, led by UCSF Quantitative Biosciences Institute Director, Nevan Krogan, PhD, reveals that some drugs may fight COVID-19...
-
News | 2018.04.16
Halima Maïnassara: from field investigator to director of CERMES in Niger
In February 2017, Dr Halima Maïnassara is the first woman from Niger to be appointed Director General of the Center for Medical and Health Research (CERMES) in Niamey. Physician, epidemiologist expert in meningitis, she started to work for this public institution, member of the Institut Pasteur International Network, in February 2005 as a field investigator.Since primary school, Halima Boubacar...
-
News | 2018.07.02
Roman Thibeaux’s joust with bacterial armor
Countering the bacteria responsible for leptospirosis by attacking the "shield" they make to protect themselves: this is the strategy that Roman Thibeaux, a young researcher at the Institut Pasteur de Nouvelle-Calédonie is trying to develop. Born on the island, he left the South Pacific region for a decade before coming back better armed.Roman Thibeaux has been immersed in a medical environment...
-
News | 2018.09.05
Meriem Ben Ali : a better diagnosis for immune deficiencies in Tunisia
Primary immunodeficiencies cause immune system anomalies in those affected, preventing an optimal defense against pathogens. These diseases linked to genetic anomalies are especially common in Tunisia owing to a high rate of consanguinity. Facing up with these pathologies, Dr. Meriem Ben Ali conducts research in the Transmission, Control and Immunobiology of Infections Laboratory of the Institut...
-
Portrait | 2018.12.04
For Asier Sáez-Cirión, research is an incurable passion
It was 35 years ago that the HIV-1 virus, responsible for AIDS, was first isolated by scientists at the Institut Pasteur. While many lives have been saved by antiretroviral therapy, there is currently no treatment that fully eliminates the virus from the body, and the search for a vaccine goes on. These challenges are driving the research of a number of scientists at the Institut Pasteur,...
-
Portrait | 2019.01.24
Lida Katsimpardi – on the hunt for an elixir of youth
Can we slow down the aging process and rejuvenate an aged brain? Can we repair a brain that has been damaged by neurodegenerative disease? Neuroscience researcher Lida Katsimpardi has been investigating these questions for the past decade. She has discovered that young blood contains proteins capable of rejuvenating an aged brain, and she has identified one of these revitalizing blood factors in...
-
Portrait | 2019.12.16
Fabrice Chrétien, from stethoscope to microscope
Fabrice Chrétien knew at a very early age that he would become a scientist. He currently heads the Neuropathology Department at Sainte-Anne Hospital in Paris and leads his own research unit at the Institut Pasteur. His research is directly inspired by the health problems experienced by his patients.It all began back in primary school for Fabrice. He was passionate about natural sciences and had...
-
Document de presse | 2021.05.21
ART Plus Combination Immunotherapy Expands Natural Killer Cells That Facilitate Control of HIV
Yerkes National Primate Research Center researchers in collaboration with Institut Pasteur have determined a combination immunotherapy of Interleukin-21 (IL-21) and interferon alpha (IFNa) is effective in generating highly functional natural killer (NK) cells that can help control and reduce simian immunodeficiency virus (SIV) in animal models. This finding is key for controlling HIV/AIDS, which...